RBP4 and hypertriglyceridemia: Higher plasma RBP4 levels were reported in insulin-resistant humans and mice [11, 13] as well as patients with type 2 diabetes [11, 14], hypertriglyceridemia [15], atherogenic dyslipidaemia [16, 17], and hypertension [18–20].